MediXall Group (MediXall Group) EV-to-EBIT : -0.44 (As of May. 11, 2024)

MediXall Group EV-to-EBIT Chart

MediXall Group Annual Data
	Trend	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22
EV-to-EBIT		Get a 7-Day Free Trial					-54.02	-47.23	-15.27	-18.81	-12.35

MediXall Group Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
EV-to-EBIT	Get a 7-Day Free Trial															-18.81	-31.94	-6.74	-3.22	-12.35

Competitive Comparison of MediXall Group's EV-to-EBIT

For the Health Information Services subindustry, MediXall Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediXall Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediXall Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MediXall Group's EV-to-EBIT falls into.

MediXall Group EV-to-EBIT Calculation

MediXall Group's EV-to-EBIT for today is calculated as:

MediXall Group's current Enterprise Value is $2.87 Mil.
MediXall Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediXall Group  (OTCPK:MDXL) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MediXall Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

MediXall Group's Enterprise Value for the quarter that ended in Dec. 2022 was $81.02 Mil.
MediXall Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.56 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediXall Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MediXall Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MediXall Group (MediXall Group) Business Description